Table 3 Differences in frequent BSM use by number of arthroplasties per year (hospital size)
Small <439 (n = 27) | Intermediate 439–720 (n = 29) | Large >720 (n = 25) | Total (n = 81) | P-value | |
|---|---|---|---|---|---|
Preoperative Autologous Donation (%) | 1 (4) | 0 | 2 (8) | 3 (4) | 0.30 |
Acute Normovolemic Hemodilution (%) | 8 (30) | 8 (28) | 10 (40) | 26 (32) | 0.59 |
Perioperative cell saver (%) | 9 (33) | 6 (21) | 10 (40) | 25 (31) | 0.29 |
Postoperative Drainage and Re-infusion (%) | 18 (67) | 20 (69) | 18 (72) | 56 (69) | 0.92 |
Erythropoietin (%) | 17 (63) | 16 (55) | 22 (88) | 55 (68) | 0.03 |
Tranexamic acid (%) | 4 (15) | 1 (3) | 5 (20) | 10 (12) | 0.16 |
Desmopressin (%) | 0 | 0 | 0 | 0 | |
Epsilon aminocaproic acid (%) | 0 | 0 | 0 | 0 | |
Fibrin glue (%) | 0 | 2 (7) | 1 (4) | 3 (4) | 0.39 |
Platelet gel (%) | 0 | 1 (3) | 0 | 1 (1) | 0.40 |
Controlled hypotension (%) | 12 (44) | 5 (21) | 9 (36) | 27 (33) | 0.16 |